article thumbnail

Leadership in the Age of Stacks

LifeSciVC

Nurses, techs, anesthesiologists, even transport staff can hold critical insight. It’s no longer just about accessing lower-cost manufacturing or early-phase trial speed. These hospitals aren’t academic centers; they function with lean staffing, limited resources, and personnel often spread across units.

article thumbnail

The Long Road to End Tuberculosis

Codon

Still, while these developments provide cause for hope, each drug or vaccine faces a variety of challenges, ranging from financial incentives for clinical trials to the difficulty of discovering new antimicrobials that pass safety and efficacy tests. A phase 3 clinical trial for M72/AS01E, funded by the Gates Foundation, began this year.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Redefining Medical Affairs Strategy with Data

H1 Blog

Now that we have more of a breadth of data where we can look at claims data and bibliometric data such as publications, claims, and trials, its really enabled us to uncover people that we might not have known in our territories. Beyond just expanding the pool of advisors, this approach has also led to more diverse perspectives.

article thumbnail

FDA Grants Priority Review for WINREVAIR Label Update Based on ZENITH Trial

The Pharma Data

FDA Grants Priority Review to Merck’s WINREVAIR™ Based on Landmark ZENITH Trial Showing Dramatic Reduction in Morbidity and Mortality in PAH Patients Merck (NYSE: MRK), operating as MSD outside the U.S. label of WINREVAIR based on compelling new evidence from the Phase 3 ZENITH trial. risk score of 9 or greater.

article thumbnail

Advancing and Safeguarding Clinical Research for a Better Tomorrow

Advarra

For more than 35 years, Advarra has been committed to protecting the rights and welfare of clinical trial participants while helping to improve healthcare outcomes, advancing medical knowledge, and bringing innovative, life-extending treatments to market that benefit millions of patients worldwide.

article thumbnail

Q&A with Advarra’s new Senior Vice President, FDA Regulatory Advisor, Jan Hewett

Advarra

From operating room nurse to IRB director to a decade as regulatory counsel at the FDA, how has each stage shaped your perspectives on regulatory policy? I began at the bedside, coordinating haematology and oncology trials and seeing what research protocol participation and decisions mean for patients and their families.

FDA
article thumbnail

Advances in nursing assessment: a fundamental step in patient care

On Medicine

Nursing assessments Nursing assessments are the basis for making diagnoses and interventions that meet the needs of the patient. Therefore, any error, lack of information or use of inadequate instruments can affect the next steps in the nursing care process, affecting the quality of care, safety and patient satisfaction.